Literature DB >> 23430811

Pyruvate dehydrogenase-e1α deficiency presenting as recurrent demyelination: an unusual presentation and a novel mutation.

Pratibha Singhi1, Linda De Meirleir, Willy Lissens, Sunit Singhi, Arushi Gahlot Saini.   

Abstract

The nucleus-encoded mitochondrial pyruvate dehydrogenase enzyme complex plays key roles in cellular energy metabolism and acid-base equilibrium. Pyruvate dehydrogenase complex deficiency is due to loss-of-function mutation in one of the five component enzymes, most commonly E1α-subunit. The common clinical presentation ranges from fatal infantile lactic acidosis in newborns to chronic neurological dysfunction. We describe here an unusual presentation of E1α-subunit deficiency presenting as recurrent demyelination, Guillain-Barré syndrome-like demyelinating polyneuropathy at the onset, and ophthalmoplegia in a young infant. The clinical phenotype of the mutation in the patient was unique as compared to the previous reported cases of pyruvate dehydrogenase deficiency. The mother was found to be a mosaic carrier of the mutation. This phenotypic variability of pyruvate dehydrogenase complex deficiency and early suspicion of its unusual neurological manifestations is highlighted. Thiamine and ketogenic diet can be helpful.

Entities:  

Year:  2013        PMID: 23430811      PMCID: PMC3755565          DOI: 10.1007/8904_2012_211

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  17 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

Review 2.  Pyruvate dehydrogenase deficiency.

Authors:  G K Brown; L J Otero; M LeGris; R M Brown
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

3.  Acute flaccid paralysis as initial symptom in 4 patients with novel E1alpha mutations of the pyruvate dehydrogenase complex.

Authors:  H M Strassburg; J Koch; J Mayr; W Sperl; E Boltshauser
Journal:  Neuropediatrics       Date:  2006-06       Impact factor: 1.947

4.  Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations.

Authors:  I D Wexler; S G Hemalatha; J McConnell; N R Buist; H H Dahl; S A Berry; S D Cederbaum; M S Patel; D S Kerr
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

5.  Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region.

Authors:  Etsuo Naito; Michinori Ito; Ichiro Yokota; Takahiko Saijo; Junko Matsuda; Yukiko Ogawa; Seiko Kitamura; Eiko Takada; Yoshihiro Horii; Yasuhiro Kuroda
Journal:  Biochim Biophys Acta       Date:  2002-10-09

6.  Neurologic crises in hereditary tyrosinemia.

Authors:  G Mitchell; J Larochelle; M Lambert; J Michaud; A Grenier; H Ogier; M Gauthier; J Lacroix; M Vanasse; A Larbrisseau
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

7.  Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1alpha subunit.

Authors:  Jessie M Cameron; Valeriy Levandovskiy; Neviana Mackay; Ingrid Tein; Brian H Robinson
Journal:  Am J Med Genet A       Date:  2004-11-15       Impact factor: 2.802

8.  Pyruvate dehydrogenase deficiency presenting as dystonia in childhood.

Authors:  R A Head; C G E L de Goede; R W N Newton; J H Walter; M A McShane; R M Brown; G K Brown
Journal:  Dev Med Child Neurol       Date:  2004-10       Impact factor: 5.449

9.  A ketogenic diet increases brain insulin-like growth factor receptor and glucose transporter gene expression.

Authors:  Clara M Cheng; Brandon Kelley; Jie Wang; David Strauss; Douglas A Eagles; Carolyn A Bondy
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

Review 10.  Inborn errors of metabolism and motor disturbances in children.

Authors:  A García-Cazorla; N I Wolf; M Serrano; B Pérez-Dueñas; M Pineda; J Campistol; E Fernández-Alvarez; J Colomer; S DiMauro; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-10       Impact factor: 4.982

View more
  4 in total

Review 1.  The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders.

Authors:  Wolfgang Sperl; Leanne Fleuren; Peter Freisinger; Tobias B Haack; Antonia Ribes; René G Feichtinger; Richard J Rodenburg; Franz A Zimmermann; Johannes Koch; Isabel Rivera; Holger Prokisch; Jan A Smeitink; Johannes A Mayr
Journal:  J Inherit Metab Dis       Date:  2014-12-20       Impact factor: 4.982

2.  Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes.

Authors:  Kalliopi Sofou; Maria Dahlin; Tove Hallböök; Marie Lindefeldt; Gerd Viggedal; Niklas Darin
Journal:  J Inherit Metab Dis       Date:  2017-01-18       Impact factor: 4.982

3.  Quantitative Proteomic and Network Analysis of Differentially Expressed Proteins in PBMC of Friedreich's Ataxia (FRDA) Patients.

Authors:  Deepti Pathak; Achal Kumar Srivastava; M V Padma; Sheffali Gulati; Moganty R Rajeswari
Journal:  Front Neurosci       Date:  2019-10-14       Impact factor: 4.677

4.  Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a 'Treatabolome'.

Authors:  May Yung Tiet; Zhiyuan Lin; Fei Gao; Matthew James Jennings; Rita Horvath
Journal:  J Neuromuscul Dis       Date:  2021
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.